Literature DB >> 21131997

Heparin responsiveness during off-pump coronary artery bypass graft surgery: predictors and clinical implications.

Duk-hee Chun1, Seong-wan Baik, So Yeon Kim, Jae Kwang Shim, Jong Chan Kim, Young Lan Kwak.   

Abstract

AIM: To evaluate the clinical impact of reduced heparin responsiveness (HR(reduced)) on the incidence of myocardial infarction (MI) following off-pump coronary artery bypass graft surgery (OPCAB), and to identify the predictors of HR(reduced).
METHODS: A total of 199 patients scheduled for elective OPCAB were prospectively enrolled. During anastomosis, 150 U/kg of heparin was injected to achieve an activated clotting time (ACT) of ≥ 300 s, and the heparin sensitivity index (HSI) was calculated. HSIs below 1.0 were considered reduced (HR(reduced)). The relationships between the HSI and postoperative MI, cardiac enzyme levels and preoperative risk factors of HR(reduced) were investigated.
RESULTS: There was no significant relationship between the HSI and cardiac enzyme levels after OPCAB. The incidence of MI after OPCAB was not higher in HR(reduced) patients. HR(reduced) occurred more frequently in patients with low plasma albumin concentrations and high platelet counts.
CONCLUSION: HR(reduced) was not associated with adverse ischemic outcomes during the perioperative period in OPCAB patients, which seemed to be attributable to a tight prospective protocol for obtaining a target ACT regardless of the presence of HR(reduced).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131997      PMCID: PMC4003313          DOI: 10.1038/aps.2010.180

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  33 in total

1.  Risk factors for fatal myocardial infarction after coronary bypass graft surgery.

Authors:  M Ranucci; A Frigiola; L Menicanti; A Cazzaniga; G Soro; G Isgrò
Journal:  Eur J Anaesthesiol       Date:  2001-05       Impact factor: 4.330

2.  Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.

Authors:  Giuseppe Patti; Annunziata Nusca; Fabio Mangiacapra; Laura Gatto; Andrea D'Ambrosio; Germano Di Sciascio
Journal:  J Am Coll Cardiol       Date:  2008-09-30       Impact factor: 24.094

3.  Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery.

Authors:  John H Lemmer; George J Despotis
Journal:  J Thorac Cardiovasc Surg       Date:  2002-02       Impact factor: 5.209

4.  Thrombin generation during reperfusion after coronary artery bypass surgery associates with postoperative myocardial damage.

Authors:  P Raivio; A Kuitunen; R Suojaranta-Ylinen; R Lassila; J Petäjä
Journal:  J Thromb Haemost       Date:  2006-07       Impact factor: 5.824

5.  Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts.

Authors:  E C Keeley; C A Velez; W W O'Neill; R D Safian
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

6.  Different patterns of heparin resistance: therapeutic implications.

Authors:  Marco Ranucci; Giuseppe Isgrò; Anna Cazzaniga; Antonio Ditta; Alessandra Boncilli; Mauro Cotza; Giovanni Carboni; Simonetta Brozzi
Journal:  Perfusion       Date:  2002-05       Impact factor: 1.972

7.  Risk factors of atrial fibrillation following off-pump coronary artery bypass graft surgery: predictive value of C-reactive protein and transfusion requirement.

Authors:  Yong Seon Choi; Jae Kwang Shim; Seong Wook Hong; Dae Hee Kim; Jong Chan Kim; Young Lan Kwak
Journal:  Eur J Cardiothorac Surg       Date:  2009-07-09       Impact factor: 4.191

8.  Stabilized infective endocarditis and altered heparin responsiveness during cardiopulmonary bypass.

Authors:  Sungwon Na; Jae Kwang Shim; Duk-Hee Chun; Dae Hee Kim; Seong Wook Hong; Young-Lan Kwak
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

9.  Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery.

Authors:  Kenichi A Tanaka; Vinod H Thourani; Willis H Williams; Peggy G Duke; Jerrold H Levy; Robert A Guyton; John D Puskas
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

10.  A case of acute myocardial infarction with repetitive stent thrombosis during emergent percutaneous coronary intervention. Transient decrease in antithrombin III activity and heparin resistance.

Authors:  Bunji Kaku; Shoji Katsuda; Tomio Taguchi; Yutaka Nitta; Yoshio Hiraiwa
Journal:  Int Heart J       Date:  2009-01       Impact factor: 1.862

View more
  2 in total

Review 1.  Optimal intraoperative anticoagulation strategy in patients undergoing off-pump coronary artery bypass.

Authors:  Sonia Rasoli; Mohamed Zeinah; Thanos Athanasiou; Antonios Kourliouros
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-03

2.  Comparison of two doses of heparin on outcome in off-pump coronary artery bypass surgery patients: A prospective randomized control study.

Authors:  Murali Chakravarthy; Dattatreya Prabhakumar; Patil Thimmannagowda; Jayaprakash Krishnamoorthy; Antony George; Vivek Jawali
Journal:  Ann Card Anaesth       Date:  2017 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.